| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.049 | 0.4 |